Medicamen Biotech Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2019 - -
Growth matrix (%)        
Revenue growth 2.36 -- -- --
Op profit growth 12.30 -- -- --
EBIT growth 0.48 -- -- --
Net profit growth 10.50 -- -- --
Profitability ratios (%)        
OPM 15.20 13.90 -- --
EBIT margin 14.80 15.10 -- --
Net profit margin 10.60 9.81 -- --
RoCE 16 -- -- --
RoNW 3.20 -- -- --
RoA 2.87 -- -- --
Per share ratios ()        
EPS 10.90 10.30 -- --
Dividend per share 0.50 1 -- --
Cash EPS 8.83 8.39 -- --
Book value per share 99.20 74 -- --
Valuation ratios        
P/E 16.60 47.20 -- --
P/CEPS 20.50 57.80 -- --
P/B 1.82 6.55 -- --
EV/EBIDTA 10.90 27.60 -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (26) (31) -- --
Liquidity ratios        
Debtor days 136 -- -- --
Inventory days 46.90 -- -- --
Creditor days (124) -- -- --
Leverage ratios        
Interest coverage (33) (20) -- --
Net debt / equity 0.07 0.04 -- --
Net debt / op. profit 0.44 0.19 -- --
Cost breakup ()        
Material costs (63) (68) -- --
Employee costs (7.60) (6.60) -- --
Other costs (14) (12) -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2019 - -
Revenue 126 123 -- --
yoy growth (%) 2.36 -- -- --
Raw materials (79) (83) -- --
As % of sales 62.90 68 -- --
Employee costs (9.50) (8.10) -- --
As % of sales 7.59 6.59 -- --
Other costs (18) (14) -- --
As % of sales 14.30 11.50 -- --
Operating profit 19.10 17 -- --
OPM 15.20 13.90 -- --
Depreciation (2.50) (2.20) -- --
Interest expense (0.60) (0.90) -- --
Other income 1.94 3.66 -- --
Profit before tax 18 17.50 -- --
Taxes (4.70) (5.50) -- --
Tax rate (26) (31) -- --
Minorities and other -- -- -- --
Adj. profit 13.30 12 -- --
Exceptional items -- -- -- --
Net profit 13.30 12 -- --
yoy growth (%) 10.50 -- -- --
NPM 10.60 9.81 -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 - -
Profit before tax 18 17.50 -- --
Depreciation (2.50) (2.20) -- --
Tax paid (4.70) (5.50) -- --
Working capital (2.60) -- -- --
Other operating items -- -- -- --
Operating cashflow 8.20 -- -- --
Capital expenditure 11.20 -- -- --
Free cash flow 19.40 -- -- --
Equity raised 171 -- -- --
Investments -- -- -- --
Debt financing/disposal -- -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 190 -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 - -
Equity capital 12.20 11.70 -- --
Preference capital -- -- -- --
Reserves 109 74.90 -- --
Net worth 121 86.60 -- --
Minority interest
Debt 11.50 11.80 -- --
Deferred tax liabilities (net) 0.41 0.41 -- --
Total liabilities 133 98.80 -- --
Fixed assets 74.20 39.10 -- --
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) 0.25 -- -- --
Net working capital 55.60 51.10 -- --
Inventories 17 15.30 -- --
Inventory Days 49.30 45.40 -- --
Sundry debtors 50 43.40 -- --
Debtor days 145 129 -- --
Other current assets 37.10 30.30 -- --
Sundry creditors (41) (31) -- --
Creditor days 120 92.40 -- --
Other current liabilities (7.20) (6.80) -- --
Cash 3.09 8.52 -- --
Total assets 133 98.80 -- --
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2020 Mar-2020 Dec-2019 Jun-2019 Mar-2019
Gross Sales 27.80 23.50 35.30 31.10 24.10
Excise Duty -- -- -- -- --
Net Sales 27.80 23.50 35.30 31.10 24.10
Other Operating Income -- -- -- -- --
Other Income 0.08 1.10 0.45 0.04 0.07
Total Income 27.90 24.60 35.80 31.20 24.20
Total Expenditure ** 23.70 20.60 29.90 26.10 19.70
PBIDT 4.17 4.05 5.89 5.05 4.45
Interest 0.24 -- 0.19 0.16 0.20
PBDT 3.93 4.05 5.70 4.89 4.25
Depreciation 0.69 0.67 0.64 0.57 0.59
Minority Interest Before NP -- -- -- -- --
Tax 0.97 0.88 1.44 1.11 1.33
Deferred Tax 0.02 0.01 (0.10) (0.10) (0.10)
Reported Profit After Tax 2.24 2.49 3.68 3.28 2.40
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 2.24 2.49 3.68 3.28 2.40
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 2.24 2.49 3.68 3.28 2.40
EPS (Unit Curr.) 3.84 2.05 3.05 2.75 2.06
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 12.20 12.20 12.20 12.20 11.70
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 15 17.20 16.70 16.20 18.50
PBDTM(%) 14.10 17.20 16.10 15.70 17.60
PATM(%) 8.06 10.60 10.40 10.50 9.97